Radical cystectomy vs. chemoradiation in T2-4aN0M0 bladder cancer: A case-control study

Urologic Oncology: Seminars and Original Investigations

Volumn 33, Issue 1, 2015, Pages 19.e1-19.e5

  Gofrit, Ofer N ^a   Nof, Rony ^a   Meirovitz, Amichai ^a   Pode, Dov ^a   Frank, Stephen ^a   Katz, Ran ^a   Shapiro, Amos ^a   Landau, Ezekiel H ^a   Hidas, Guy ^a   Yutkin, Vladimir ^a   Duvdevani, Mordechai ^a   Wygoda, Mark ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Chemoradiation; Muscle invasive bladder cancer; Radical cystectomy

Indexed keywords

CARBOPLATIN; CISPLATIN; GEMCITABINE;

AGED; AREA UNDER THE CURVE; ARTICLE; BLOOD TRANSFUSION; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CHARLSON COMORBIDITY INDEX; CHEMORADIOTHERAPY; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; CYSTECTOMY; DISEASE FREE SURVIVAL; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GASTROINTESTINAL DISEASE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; ILEAL CONDUIT; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; KIDNEY FAILURE; KIDNEY FUNCTION; MALE; MULTIMODALITY CANCER THERAPY; MUSCLE INVASIVE BLADDER CANCER; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSTOPERATIVE CARE; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION INJURY; SALVAGE THERAPY; SURVIVAL RATE; UROGENITAL TRACT DISEASE; CANCER STAGING; CASE CONTROL STUDY; COMPARATIVE STUDY; PATHOLOGY; RETROSPECTIVE STUDY; TUMOR INVASION; URINARY BLADDER NEOPLASMS;

AGED; CASE-CONTROL STUDIES; CHEMORADIOTHERAPY; CYSTECTOMY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; NEOPLASM INVASIVENESS; NEOPLASM STAGING; RETROSPECTIVE STUDIES; URINARY BLADDER NEOPLASMS;

EID: 84922637675     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2014.09.014     Document Type: Article

References (27)

1. Gakis G., Efstathiou J., Lerner S.P., et al. CUD-EAU International Consultation on Bladder Cancer 2012: radical cystectomy and bladder preservation for muscle-invasive urothelial carcinoma of the bladder. Eur Urol 2013, 63:45-57.
2. Grossman H.B., Natale R.B., Tangen C.M., et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med 2003, 349:859-866.
3. Stein J.P., Lieskovsky G., Cote R., et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 2001, 19:666-675.
4. Efstathiou J.A., Spiegel D.Y., Shipley W.U., et al. Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experience. Eur Urol 2012, 61:705-711.
5. Efstathiou J.A., Bae K., Shipley W.U., et al. Late pelvic toxicity after bladder-sparing therapy in patients with invasive bladder cancer: RTOG 89-03, 95-06, 97-06, 99-06. J Clin Oncol 2009, 27:4055-4061.
6. Danesi D.T., Arcangeli G., Cruciani E., et al. Conservative treatment of invasive bladder carcinoma by transurethral resection, protracted intravenous infusion chemotherapy, and hyperfractionated radiotherapy: long term results. Cancer 2004, 101:2540-2548.
7. Kotwal S., Choudhury A., Johnston C., et al. Similar treatment outcomes for radical cystectomy and radical radiotherapy in invasive bladder cancer treated at a United Kingdom specialist treatment center. Int J Radiat Oncol Biol Phys 2008, 70:456-4563.
8. Chahal R., Sundaram S.K., Iddenden R., et al. A study of the morbidity, mortality and long-term survival following radical cystectomy and radical radiotherapy in the treatment of invasive bladder cancer in Yorkshire. Eur Urol 2003, 43:246-257.
9. Charlson M.E., Pompe P., Ales K., et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40:373-383.
10. Dindo D., Demartines N., Clavien P.A. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004, 240:205-213.
11. Common Terminology Criteria for Adverse Events v4.0 (CTCAE). http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE.
12. Cox J.D., Stetz J., Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995, 31:1341-1346.
13. Madersbacher S., Hochreiter W., Burkhard F., et al. Radical cystectomy for bladder cancer today: a homogeneous series without neoadjuvant therapy. J Clin Oncol 2003, 21:690-696.
14. Hautmann R.E., Gschwend J.E., de Petriconi R.C., et al. Cystectomy for transitional cell carcinoma of the bladder: results of a surgery only series in the neobladder era. J Urol 2006, 176:486-492.
15. James N.D., Hussain S.A., Hall E., et al. Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer. N Engl J Med 2012, 366:1477-1488.
16. Zapatero A., Martin De Vidales C., et al. Long-term results of two prospective bladder-sparing trimodality approaches for invasive bladder cancer: neoadjuvant chemotherapy and concurrent radio-chemotherapy. Urology 2012, 80:1056-1062.
17. Sabaa M.A., El-Gamal O.M., Abo-Elenen M., et al. Combined modality treatment with bladder preservation for muscle invasive bladder cancer. Urol Oncol 2010, 28:14-20.
18. Rödel C., Grabenbauer G.G., Kühn R., et al. Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results. J Clin Oncol 2002, 20:3061-3071.
19. Haresh K.P., Julka P.K., Sharma D.N., et al. A prospective study evaluating surgery and chemo radiation in muscle invasive bladder cancer. J Cancer Res Ther 2007, 3:81-85.
20. Maarouf A.M., Khalil S., Salem E.A., et al. Bladder preservation multimodality therapy as an alternative to radical cystectomy for treatment of muscle invasive bladder cancer. BJU Int 2011, 107:1605-1610.
21. Arias F., Domínguez M.A., Martínez E., et al. Chemoradiotherapy for muscle invadingbladder carcinoma. Final report of a single institutional organ-sparing program. Int J Radiat Oncol Biol Phys 2000, 47:373-378.
22. Oh K.S., Soto D.E., Smith D.C., et al. Combined-modality therapy with gemcitabine andradiation therapy as a bladder preservation strategy: long-term results of a phase I trial. Int J Radiat Oncol Biol Phys 2009, 74:511-517.
23. Gospodarowicz M. Radiotherapy and organ preservation in bladder cancer: are we ignoring the evidence?. J Clin Oncol 2002, 20:3048-3050.
24. Caffo O., Fellin G., Graffer U., et al. Assessment of quality of life after cystectomy or conservative therapy for patients with infiltrating bladder carcinoma. A survey by a self-administered questionnaire. Cancer 1996, 78:1089-1097.
25. Henningsohn L., Steven K., Kallestrup E.B., et al. Distressful symptoms and well-being after radical cystectomy and orthotopic bladder substitution compared with a matched control population. J Urol 2002, 168:168-174.
26. Zietman A.L., Sacco D., Skowronski U., et al. Organ conservation in invasive bladder cancer by transurethral resection, chemotherapy and radiation: results of a urodynamic and quality of life study on long-term survivors. J Urol 2003, 170:1772-1776.
27. Eswara J.R., Efstathiou J.A., Heney N.M., et al. Complications and long-term results of salvage cystectomy after failed bladder sparing therapy for muscle invasive bladder cancer. J Urol 2012, 187:463-468.